The European Congress on Neurology and Brain Disorders, scheduled for April 28-29, 2025, in Lisbon, Portugal, will gather neurology experts and professionals from around the globe. Together, we will collaborate to advance our understanding and treatment of neurological conditions, striving to reduce their impact through innovation in prevention, therapy, and rehabilitation.
Join us to engage with leading neurologists and researchers, explore the latest scientific breakthroughs, clinical trials, and guidelines in neurology and brain disorders. Connect with a global network dedicated to enhancing neurological care through knowledge-sharing, skill-building workshops, and impactful research.
Let's unite to drive forward advancements in neurology and ensure better outcomes for patients worldwide at the European Congress on Neurology and Brain Disorders in Lisbon, Portugal.
Abstract Submission Deadline: March 12, 2025
Early Bird Registration: Feb 18, 2025
Mid Term Registration: March 14, 2025
Final/Onsite Registration: Apr 28, 2025
Professor, Aristotle University of Thessaloniki
Greece
Professor, Dalian Medical University
China
Associate Professor, Mass General Research Institute
USA
Professor, Appalachian State University
USA
Professor, University Cattolica del Sacro Cuore
Italy
University of Patras
Greece
Professor, Queen Marry University London
United Kingdom
Assistant Professor, Indiana University School of Medicine
USA
Assistant Professor, University of Kragujevac
Serbia
Professor, Dalian Medical University
China
King's College Healthcare Partners
United Kingdom
Dear Attendees, Guests and Colleagues,
Welcome to the [Neurology Congress 2025]! On behalf of the organizing committee, I extend a warm greeting to you as we embark on a journey of knowledge exploration and scholarly exchange. We are delighted to have you join us for this esteemed gathering of academic minds from around the world. First and foremost, I would like to express our sincere gratitude for your participation in this conference. Your presence enriches our discussions and contributes to the vibrant intellectual community that we strive to foster. We have curated an exciting lineup of keynote speakers, panel discussions, and research presentations that promise to inspire and stimulate intellectual curiosity in Neurology.
From groundbreaking research findings to thought-provoking debates, this conference offers a unique opportunity to engage with cutting-edge scholarship and connect with fellow academics. As you navigate through the conference sessions and engage in conversations with your peers, I invite you to embrace the spirit of inquiry, curiosity, and collaboration that defines our academic community. Together, let us explore new frontiers of knowledge, challenge conventional wisdom, and inspire positive change in our respective fields. Once again, thank you for joining us at the [Neurology Congress 2025]. Your presence is instrumental in making this event a resounding success, and we look forward to the invaluable contributions you will make to our collective pursuit of academic excellence.
Warm regards,
Weidong Le
Professor, Dalian Medical University, China
Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, ‘omics association analysis).
For a comprehensive perspective of primary research, commentaries, and reviews related to personalized medicine, also termed precision medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.
Topics of interest with a view towards personalized medicine include (but are not limited to) the following:
Omics-based studies of disease risk, disease prognosis, and response to therapy
Biomarker identification and application
Drug target discovery and integration with individualized therapy
Pharmacogenomics – genetics and biochemistry of drug uptake, action, and metabolism
Prediction-based drug safety
Novel therapeutics: genetic-based, nanotechnology, targeting strategies
Advancements in Technologies and Resources
Genetic testing, sequencing technologies, and molecular diagnostics
Expression analysis, metabolomics, proteomics
Microbiomes
Genome-wide association studies
Bioinformatics and health informatics
Biostatistics
Personalization of omics-based non-drug related health interventions
Regulation and bioethics in personalized medicine
For further information of the journal, please see
https://www.mdpi.com/journal/jpm